RecruitingNot ApplicableNCT05874843

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients


Sponsor

Indiana University

Enrollment

125 participants

Start Date

Sep 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.


Eligibility

Min Age: 3 MonthsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Thromboelastography (TEG 6S) for people with coagulopathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Months to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTThromboelastography (TEG 6S)

The TEG 6s assays are performed in a microfluidic cartridge which only requires a small amount of a patient's blood be transferred to the cartridge for analysis. The vibration frequency of the blood meniscus at which resonance occurs is used to create a clot dynamics tracing.


Locations(1)

Riley Hospital for Children

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05874843


Related Trials